China Palliative Care Market Analysis Report [2022-30]

China Palliative Care Market Analysis

$ 3999

The China Palliative care market is projected to grow from $1.05 Bn in 2022 to $2.17 Bn by 2030, registering a CAGR of 9.5% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, the rising prevalence of chronic diseases, increasing awareness and government support. The market is segmented by service type and by the end user. Some of the major players include Beijing Haidian Hospital, Fudan University Shanghai Cancer Center, Shanghai Children’s Medical Center and Jigan Temple Community Hospital.

ID: IN10CNHS013 CATEGORY: Healthcare Services GEOGRAPHY: China AUTHOR: Neha Davda

Buy Now

China Palliative Management Market Executive Summary

The China Palliative care market is projected to grow from $1.05 Bn in 2022 to $2.17 Bn by 2030, registering a CAGR of 9.5% during the forecast period of 2022 - 2030. China's health spending grew from 5.17% of GDP in 2018 to 5.35% in 2019. In developing countries, where it normally hovers around 10%, the cost of healthcare as a percentage of GDP is still lower.

A specialised type of medical treatment for those with life-threatening illnesses is palliative care. This sort of care's main goal is to relieve stress and the symptoms of the condition. The objective is to enhance the patient's and their family's quality of life. A professionally trained group of physicians, nurses, and other professionals who collaborate with a patient's medical providers to offer an additional level of support is known as palliative care. Palliative care puts more emphasis on the patient's needs than their prognosis. It can be used in conjunction with curative therapy for serious illnesses at any age or stage.

The palliative care market in China is rapidly growing. Hospices have been established in China since 1987, and as of June 2017, there were about 2,300 hospice groups there, according to the national health administration, however, they typically only exist in developed cities.

China Palliative Care Market Analysis

Market Dynamics

Market Growth Drivers

The China palliative care market is expected to be driven by factors such as the ageing population, the rising prevalence of chronic diseases, increasing awareness and government support. Further, palliative care is important, and the Chinese government has taken action to encourage its growth.

Market Restraints

The decision of where to die is made more challenging by China's current policy environment. Opioid painkiller distribution is severely constrained outside of hospitals, and hospital inpatient treatments are covered by China's social health insurance program at greater rates than other forms of care. Additionally, there is still very little access to palliative care, with Shanghai being the only Chinese city with a social insurance scheme that includes such services. Patients currently frequently opt to keep receiving therapy rather than participate in end-of-life care programs. These factors limit the growth of palliative care services in the market.

Competitive Landscape

Key Players

Beijing Haidian Hospital (CHN)
Fudan University Shanghai Cancer Center (CHN)
Shanghai Children’s Medical Center (CHN)
Jigan Temple Community Hospital (CHN)

Healthcare Policies and Regulatory Landscape

The Chinese government has put in place a number of rules and regulations to guarantee that patients are given access to high-quality palliative care services. The development of a national hospice and palliative care centre and the integration of palliative care into the national healthcare system are some recent examples of the Chinese government's attempts to improve the palliative care system.

The "Guidelines for Standardized Hospice and Palliative Care Services," released by the National Health Commission in 2018, is an important regulation in the palliative care industry. These recommendations offer a framework for delivering high-quality palliative care services, which include the formation of palliative care teams, the management of pain and symptoms, and the provision of emotional and spiritual support to those who need it.

The "Hospice and Palliative Care Service Payment Standard," which was released by the National Healthcare Security Administration and Ministry of Finance in 2019, is another significant regulation. By offering financial incentives to healthcare professionals who provide these services, this program seeks to promote the growth of palliative care services. Along with these measures, the Chinese government has also put in place rules to regulate the use of opioid drugs, a vital part of palliative care. Two significant laws that govern the manufacture, sale, and use of opioid drugs in China are the "Regulations on the Management of Narcotic Drugs and Psychotropic Substances" and the "Measures for the Administration of Opioid Drugs."

Reimbursement Scenario

The national healthcare system's inclusion of palliative care services is a crucial reimbursement strategy. In order to ensure that hospice and palliative care treatments are covered by the country's healthcare system, the Chinese government added these services to the National Essential Medicines List in 2016. Palliative care is now more readily available to patients, particularly those who cannot afford private healthcare services. The Chinese government has also created measures to assist private healthcare providers that provide palliative care services in addition to the state healthcare system. Private healthcare providers who provide palliative care services are given financial incentives through the "Hospice and Palliative Care Service Payment Standard," making it more feasible for them to do so.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Palliative Care Market Segmentation

By Service Type (Revenue, USD Billion):

Based on service type, the China palliative care market is divided into the following:

Private residence care
Hospice inpatient care
Hospital inpatient care
Nursing home and residential facility care
Others

By End User (Revenue, USD Billion):

Based on end-user type, the China palliative care market is divided into the following:

Hospitals
Home Care Settings
Palliative Care Centers
Long-Term Care Centers & Rehabilitation Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.